Differential in vivo inhibition of [3H]nemonapride binding by atypical antipsychotics in rat striatum, olfactory lobes, and frontal cortex

Pharmacology

Volumn 75, Issue 2, 2005, Pages 63-68

  Assie M B ^a   Consul Denjean, N ^a   Koek, W ^a   Newman Tancredi, A ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

3H nemonapride; D2 like receptors; Frontal cortex; In vivo binding; Olfactory lobes

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CLOZAPINE; DOPAMINE 2 RECEPTOR; EMONAPRIDE; HALOPERIDOL; RACLOPRIDE; RISPERIDONE; SPIPERONE; THIORIDAZINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; BRAIN REGION; CONTROLLED STUDY; CORPUS STRIATUM; DOSE RESPONSE; FRONTAL CORTEX; MALE; NONHUMAN; OLFACTORY CORTEX; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPSYCHOTIC AGENTS; BENZAMIDES; CORPUS STRIATUM; FRONTAL LOBE; MALE; OLFACTORY PATHWAYS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE D2; TRITIUM;

EID: 24744460478     PISSN: 00317012     EISSN: None     Source Type: Journal    
DOI: 10.1159/000086948     Document Type: Article

References (19)

1. 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol Psychiatry 2001;50:873-883.
2. 3 dopamine receptor antagonist activity and limbic selectivity. J Pharmacol Exp Ther 1997;280:73-82.
3. 125I]epidepride. Eur J Pharmacol 1995;286:R3-R5.
4. 2 dopamine receptor blockade with haloperidol or new antipsychotic drugs in patients with schizophrenia. Br J Psychiatry 2001;179:503-508.
5. Arnt J, Skarsfeldt T: Do novel antipsychotics have similar pharmacological characteristics? A review of the evidence. Neuropsychopharmacology 1998;18:63-101.
6. 4 receptors. Br J Pharmacol 1996;117:1625-1632.
7. 2 receptor binding of antipsyckotics in vivo. Pharmacol Biochem Behav 1994;49:165-169.
8. 1A receptors in rat brain. Eur J Pharmacol 1994;271:515-523.
9. Koek W, Colpaert FC: Inhibition of methylphenidate-induced behaviors in rats: differences among neuroleptics. J Pharmacol Exp Ther 1993;267:181-191.
10. 2 receptor group, in the rat brain and spinal cord. J Comp Neurol 1994;344:121-136.
11. 3H]YM-09151-2 (nemonapride), a potent radioligand for both sigma 1 and sigma 2 receptor subtypes. Neuroreport 1996;7:1057-1061.
12. 3H]raclopride for dopamine D-2 receptor binding to rat striatum. Eur J Pharmacol 1989;173:177-182.
13. i values. J Pharmacol Exp Ther 1989;251:238-246.
14. Leysen JE, Janssen PMF, Gommeren W, Wynants J, Pauwels PJ, Janssen PAJ: In vitro and in vivo receptor binding and effects on monoamine turnover in rat brain regions of the novel antipsychotics risperidone and ocaperidone. Mol Pharmacol 1992;41:494-508.
15. Kapur S, Seeman P: Antipsychotic agents differ in how fast they come off the dopamine D2 receptors: implications for atypical antipsychotic action. J Psychiatry Neurosci 2000;25:161-166.
16. 2 receptor explain the action of atypical antipsychotics? A new hypothesis. Am J Psychiatry 2001;158:360-369.
17. Rowley HL, Needham PL, Kilpatrick IC, Heal DJ: A comparison of the acute effects of zotepine and other antipsychotics on rat cortical dopamine release, in vivo. Naunyn Schmiedebergs Arch Pharmacol 2000;361:187-192.
18. Kuroki T, Meltzer HY, Ichikawa J: Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens. J Pharmacol Exp Ther 1999;288:774-781.
19. Laruelle M: Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. J Cereb Blood Flow Metab 2000;20:423-451.